BioAdaptives, Inc.
BDPT
$0.00
$0.00-29.83%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -47.12% | 126.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -47.12% | 126.09% | |||
| Cost of Revenue | -50.00% | 250.00% | |||
| Gross Profit | -46.05% | 94.87% | |||
| SG&A Expenses | -21.01% | -5.15% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.20% | -4.37% | |||
| Operating Income | 20.11% | 6.62% | |||
| Income Before Tax | 86.51% | -116.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 86.51% | -116.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 86.51% | -116.94% | |||
| EBIT | 20.11% | 6.62% | |||
| EBITDA | 20.24% | 6.66% | |||
| EPS Basic | 86.40% | -84.37% | |||
| Normalized Basic EPS | 86.94% | -51.02% | |||
| EPS Diluted | 85.38% | -84.37% | |||
| Normalized Diluted EPS | 86.94% | -51.02% | |||
| Average Basic Shares Outstanding | -0.18% | 17.49% | |||
| Average Diluted Shares Outstanding | -0.18% | 17.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||